《中国经皮冠状动脉介入治疗指南(2016)》指导急性冠状动脉综合征的临床实践

[1] 解读欧美指南——再议新型P2Y12抑制剂治疗地位 [J]. 中国介入心脏病学杂志, 2015, 23 (01) : 55 - 58

[2] 最新ACC/ESC血小板糖蛋白Ⅱb/Ⅲa抑制剂相关指南解读 [J]. 中国介入心脏病学杂志, 2014, 22 (12) : 814 - 816

[3] 推动我国医疗急救体系建设:从急性心肌梗死救治开始[J]. 张岩,霍勇.北京大学学报(医学版). 2014(06)

[4] Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial[J] . Yuichi J. Shimada,Sameer Bansilal,Stephen D. Wiviott,Richard C. Becker,Robert A. Harrington,Anders Himmelmann,Benjamin Neely,Steen Husted,Stefan K. James,Hugo A. Katus,Renato D. Lopes,Ph. Gabriel Steg,Robert F. Storey,Lars Wallentin,Christopher P. Cannon.American Heart

[5] Manual Thrombus Aspiration during Primary Percutaneous Coronary Intervention: Impact of Total Ischemic Time[J] . Doo Sun Sim,Myung Ho Jeong,Youngkeun Ahn,Young Jo Kim,Shung Chull Chae,Taek Jong Hong,In Whan Seong,Jei Keon Chae,Chong Jin Kim,Myeong Chan Cho,Seung-Woon Rha,Jang Ho Bae,Ki Bae Seung,Seung Jung Park.Journal of Cardiology . 2016

[6] Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial[J] . Thomas Engstr?m,Henning Kelb?k,Steffen Helqvist,Dan Eik H?fsten,Lene Kl?vgaard,Lene Holmvang,Erik J?rgensen,Frants Pedersen,Kari Saunam?ki,Peter Clemmensen,Ole De Backer,Jan Ravkilde,Hans-Henrik Tilsted,Anton Boel Villadsen,Jens Aar?e,Svend Eggert Jensen,Bent Raungaard,Lars K

[7] Target-Vessel Versus Multivessel Revascularisation in ST-Elevation Myocardial Infarction: A Meta-Analysis of Randomised Trials[J] . Kiran Sarathy,Vinayak Nagaraja,Amit Kapur,Richard Szirt,Jwalant Raval,Guy D. Eslick,David Burgess,A. Robert Denniss.Heart, Lung and Circulation . 2014

[8] Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI)[J] . Circulation . 2008 (3)

[1] 解读欧美指南——再议新型P2Y12抑制剂治疗地位 [J]. 中国介入心脏病学杂志, 2015, 23 (01) : 55 - 58

[2] 最新ACC/ESC血小板糖蛋白Ⅱb/Ⅲa抑制剂相关指南解读 [J]. 中国介入心脏病学杂志, 2014, 22 (12) : 814 - 816

[3] 推动我国医疗急救体系建设:从急性心肌梗死救治开始[J]. 张岩,霍勇.北京大学学报(医学版). 2014(06)

[4] Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial[J] . Yuichi J. Shimada,Sameer Bansilal,Stephen D. Wiviott,Richard C. Becker,Robert A. Harrington,Anders Himmelmann,Benjamin Neely,Steen Husted,Stefan K. James,Hugo A. Katus,Renato D. Lopes,Ph. Gabriel Steg,Robert F. Storey,Lars Wallentin,Christopher P. Cannon.American Heart

[5] Manual Thrombus Aspiration during Primary Percutaneous Coronary Intervention: Impact of Total Ischemic Time[J] . Doo Sun Sim,Myung Ho Jeong,Youngkeun Ahn,Young Jo Kim,Shung Chull Chae,Taek Jong Hong,In Whan Seong,Jei Keon Chae,Chong Jin Kim,Myeong Chan Cho,Seung-Woon Rha,Jang Ho Bae,Ki Bae Seung,Seung Jung Park.Journal of Cardiology . 2016

[6] Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial[J] . Thomas Engstr?m,Henning Kelb?k,Steffen Helqvist,Dan Eik H?fsten,Lene Kl?vgaard,Lene Holmvang,Erik J?rgensen,Frants Pedersen,Kari Saunam?ki,Peter Clemmensen,Ole De Backer,Jan Ravkilde,Hans-Henrik Tilsted,Anton Boel Villadsen,Jens Aar?e,Svend Eggert Jensen,Bent Raungaard,Lars K

[7] Target-Vessel Versus Multivessel Revascularisation in ST-Elevation Myocardial Infarction: A Meta-Analysis of Randomised Trials[J] . Kiran Sarathy,Vinayak Nagaraja,Amit Kapur,Richard Szirt,Jwalant Raval,Guy D. Eslick,David Burgess,A. Robert Denniss.Heart, Lung and Circulation . 2014

[8] Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI)[J] . Circulation . 2008 (3)